Healthcare · Biotechnology
Price
$3.79
Market Cap
$1.7M
Employees
11
Beta
0.93
Avg Volume
53,333
CEO
Ronen Twito
Business Description
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Business History
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.14
Stock Price: $3.79
EPS (Diluted): -26.30
EPS (Diluted): -26.30
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
1.13
Stock Price: $3.79
Total Equity: $1.41M
Shares: 154,328
Total Equity: $1.41M
Shares: 154,328
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.02
Market Cap: $1.71M
Total Debt: $0.00
Cash: $1.67M
EBITDA: -$3.63M
Total Debt: $0.00
Cash: $1.67M
EBITDA: -$3.63M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$-76,565
Market Cap: $1.71M
Total Debt: $0.00
Cash: $1.67M
Total Debt: $0.00
Cash: $1.67M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $3.79
Revenue: $0.00
Shares: 154,328
Revenue: $0.00
Shares: 154,328
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: -$3,321
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$4.38M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$1.98M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-140.8%
Net Income: -$1.98M
Total Equity: $1.41M
Total Equity: $1.41M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
1,690.9%
Operating Income: -$4.38M
Tax Rate: 0.0%
Equity: $1.41M
Total Debt: $0.00
Cash: $1.67M
Tax Rate: 0.0%
Equity: $1.41M
Total Debt: $0.00
Cash: $1.67M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.69
Current Assets: $2.23M
Current Liabilities: $826,764
Current Liabilities: $826,764
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $1.41M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $1.41M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 154,328
Shares: 154,328
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$9.11
Total Equity: $1.41M
Shares: 154,328
Shares: 154,328
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-27.68
Operating CF: -$4.27M
CapEx: -$3,917
Shares: 154,328
CapEx: -$3,917
Shares: 154,328
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $3.79
Stock Price: $3.79
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$1.98M
Net Income: -$1.98M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares NCEL against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 23, 2026 9:29pm (3d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $10,050 | $11,408 | $11,408 | $3,321 |
| Gross Profit | $0 | $-10,050 | $-11,408 | $-11,408 | $-3,321 |
| Operating Expenses | $2.3M | $11.9M | $15.5M | $11.8M | $4.4M |
| Operating Income | -$2.3M | -$11.9M | -$15.5M | -$11.8M | -$4.4M |
| Net Income | -$2.9M | -$11.9M | -$16.5M | -$12.2M | -$2.0M |
| EBITDA | $69.6M | -$11.9M | -$15.5M | -$11.8M | -$3.6M |
| EPS | $-5.90 | $-8.10 | $-8.40 | $-3.20 | $-26.30 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 9:29pm (3d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $93,710 | $5.4M | $8.9M | $897,680 | $1.7M |
| Total Current Assets | $196,711 | $5.7M | $9.2M | $1.8M | $2.2M |
| Total Assets | $1.2M | $5.8M | $9.3M | $1.8M | $2.2M |
| Current Liabilities | $7.2M | $2.4M | $3.4M | $7.9M | $826,764 |
| Long-Term Debt | $313,478 | $0 | $0 | $0 | $0 |
| Total Liabilities | $10.2M | $5.2M | $6.0M | $10.7M | $826,764 |
| Total Equity | -$9.0M | $542,388 | $3.3M | -$8.8M | $1.4M |
| Retained Earnings | -$29.8M | -$41.7M | -$58.2M | -$70.4M | -$74.4M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 9:29pm (3d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-729,386 | -$14.9M | -$13.9M | -$9.7M | -$4.3M |
| Capital Expenditure | $-4 | $-39,560 | $0 | $-4 | $-3,917 |
| Free Cash Flow | $-729,386 | -$15.0M | -$13.9M | -$9.7M | -$4.3M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-126,557 | $5.3M | $3.5M | -$8.1M | $767,715 |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 4:50pm (16h ago)| Metric | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Revenue | $0 | $0 |
$132.5M $132.5M – $132.5M
|
$178.6M $178.6M – $178.6M
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
-$2.5M -$2.5M – -$2.5M
|
-$27.8M -$27.8M – -$27.8M
|
$69.8M $69.8M – $69.8M
|
$106.2M $106.2M – $106.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 9:29pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | — | -13.5% | +0.0% | +70.9% |
| Operating Income Growth | -415.8% | -30.5% | +23.7% | +62.9% |
| Net Income Growth | -317.5% | -38.1% | +26.2% | +83.7% |
| EBITDA Growth | -117.0% | -30.6% | +23.8% | +69.2% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for NCEL — it's generated by the pipeline (
market-narrative step).
No community reviews yet for NCEL.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30